A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2004
12/15/2004	CN1555356A Bisphenol derivative as NHE-3 inhibitor
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/15/2004	CN1555253A Oily composition of taxol,preparation for chemical therapeutic embolism and their producing method
12/15/2004	CN1554748A Method for preparing megakaryocytic preparation by amplifying macronucleus ancestral cell and mature megacaryocyte and use
12/15/2004	CN1554671A Process for preparing low moledule heparin calcium of low nitrite content
12/15/2004	CN1554433A Method for preparing Qingkailing freezo dried powder injection for injection
12/15/2004	CN1554410A Worm nutritiou health oral liquid and its preparing method
12/15/2004	CN1554406A Medicine for tonifying kidney, strengthening spleen, replenishing esseuce and invigorating marrow and its preparing method
12/15/2004	CN1554386A Medicine for treating anemia and preparing method
12/15/2004	CN1554360A Use of Holothuria Leuospilota polysaccharide in preparing anticoagulant medicine and angiogenesis inhibitor
12/15/2004	CN1554353A High content troxerutin medicine and its preparing method
12/15/2004	CN1554327A Plaster for promoting peristalsis and urination after operation
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179741C Compound Chinese medicine for treating cerebrovascular disease
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831159 Method for purifying factor VIII/vWF company by cation-exchange chromatography
12/14/2004	US6831157 Process for the purification of serum albumin
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	CA2261597C Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/09/2004	WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7)
12/09/2004	WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
12/09/2004	WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use
12/09/2004	WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040249155 1-(omego-substituted-2-[(hetero)arylcarbonylamino]alkanoyl)-4-(1-methylpiperidin-4-yl)piperidine derivatives; e.g., 1-[N-(Indole-6-carbonyl)-D-serinyl]-4-(1-methylpiperidin-4-yl)piperidine Hydrochloride
12/09/2004	US20040249151 Chemical compounds
12/09/2004	US20040249134 Factor viii c2 domain variants
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248981 Excellent inhibitory activity against factor Xa; anticoagulants; blood coagulation disorder, thrombotic disease, cerebral infarction, myocardial infarction, or peripheral circulation disorder
12/09/2004	US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/09/2004	US20040248895 Novel guanidino compounds
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248852 Chemical compounds
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents
12/09/2004	US20040248817 Therapy for cardiovascular disorders; hypotensive agents; congestive heart failure
12/09/2004	US20040248813 Compounds and methods for the modulation of cd154
12/09/2004	US20040248797 Pharmaceutical compositions of erythropoietin
12/09/2004	US20040248796 VEGF-B and PDGF modulation of stem cells
12/09/2004	US20040248793 Stabilised solid compositions of factor VII polypeptides
12/09/2004	US20040248785 mutant factor VIII has procoagulant activity; increased half-life; substituted amino acid(s) in the A2 domain
12/09/2004	US20040248768 Nutritional composition preventing bacterial overgrowth
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040247643 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
12/09/2004	US20040247642 Instrument coated with magnesium-based compound for reducing thrombosis
12/09/2004	US20040247594 Activating T lymphocytes of several to all sub-groups without an occupation of an antigen receptor of the lymphocytes; for use in treating granulocytopenia, thrombocytopenia, aplastic anemias or bone marrow failures with aplasia/hypoplasia of the bone marrow and pancytopenia
12/09/2004	US20040247564 Treating a tissue disorder involving a loss and/or apoptosis of cells by administering an agent that induces phosphorylation and/or activation of protein kinase B to cause proliferation; particularly administering a human stromal-derived factor-1 and a G-CSF to cause proliferation of cardiomyocytes
12/09/2004	US20040246627 Disc drive pivot bearing assembly
12/09/2004	CA2820174A1 Low sodium solution for dialysis
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1484059A2 Antiviral composition comprising phenylacetic acid derivatives
12/08/2004	EP1484058A2 Pharmaceutical composition for inhibiting altering gene expression and for inducing differentiation in non-malignant cells
12/08/2004	EP1483978A1 Biological process for the production of a food product comprising heme-iron and food product obtained with said process
12/08/2004	EP1483380A2 Recombinant protein c variants
12/08/2004	EP1483285A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME
12/08/2004	EP1483284A2 Selective dipeptide inhibitors of kallikrein
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483240A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity
12/08/2004	EP1482988A1 METHOD OF RADIO−LABELLING BIOMOLECULES
12/08/2004	EP1482969A2 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence
12/08/2004	EP1482954A2 Alpha-substituted arylalkyl phosphonate derivatives
12/08/2004	EP1482953A1 Alpha-substituted heteroarylalkyl phosphonate derivattives
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1220693B1 Formulations for delivery of osteogenic proteins
12/08/2004	EP1143797A4 Methods for reducing adverse side effects associated with cellular transplantation
12/08/2004	CN1553817A Method for improving oxygen transport by stored red blood cells
12/08/2004	CN1553811A Human tissue urokinase type plasminogen activator formulation
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552431A Chinese medicinal preparation for lowering viscosity and preventing embolism
12/08/2004	CN1552413A Internal medicine for treating SARS, AIDS virus, preparing method and use thereof
12/08/2004	CN1552406A Preparation of water soluble dragon's blood as medicine
12/08/2004	CN1552385A Medicine for treating hydrops and hydroncus and preparing method thereof
12/08/2004	CN1552378A Blood regenerating pills and their preparation
12/08/2004	CN1552366A Donkey hide gelatin and Chinese angelica nourishing blood pills and their preparation
12/08/2004	CN1552358A Compound donkeyhide gelatin blood-tonifying pill and preparing method thereof
12/08/2004	CN1552355A Rue extract preparing method
12/08/2004	CN1552329A Powder injection of cefpiramide
12/08/2004	CN1179026C Fat compositions
12/08/2004	CN1178905C Novel peptide derivative

1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 671